Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases-Reference-Cited by-同舟云学术

Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases

Published:2021-08-23 Issue:5 Volume:29 Page:1291-1306
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Khalesi Naeemeh,Korani Shahla,Korani Mitra,Johnston Thomas P.,Sahebkar Amirhossein^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-021-00863-2.pdf

Reference110 articles.

1. Adams J (2001) Proteasome inhibition in cancer: development of PS-341. Semin Oncol 28(6):613–619

2. Adams J (2002a) Proteasome inhibitors as new anticancer drugs. Curr Opin Oncol 14(6):628–634

3. Adams J (2002b) Development of the proteasome inhibitor PS-341. Oncologist 7(1):9–16

4. Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4(5):349–360

5. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD et al (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59(11):2615–2622

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target;BMC Cancer;2024-06-10

2. Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations;Diagnostics;2024-05-29

3. A REVIEW ON MACROPHAGES AND THE IMPACT OF PROTEASOME INHIBITORS ON RHEUMATOID ARTHRITIS;International Journal of Pharmacy and Pharmaceutical Sciences;2024-05-01

4. Hemolytic Anemia Induced by Infectious Agents: Diagnostic and Treatment approaches;2024 International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG);2024-04-02

5. B-cells in pulmonary arterial hypertension: friend, foe or bystander?;European Respiratory Journal;2024-03-14